These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
637 related articles for article (PubMed ID: 5701557)
81. Uremic bone disease: current knowledge, controversial issues, and new horizons. Malluche HH; Monier-Faugere MC Miner Electrolyte Metab; 1991; 17(4):281-96. PubMed ID: 1813791 [TBL] [Abstract][Full Text] [Related]
82. [Application of bone densitometry for detection of renal osteodystrophy in patients on maintenance haemodialysis]. Tomanoski V Srp Arh Celok Lek; 1994; 122(1-2):10-3. PubMed ID: 17972792 [TBL] [Abstract][Full Text] [Related]
83. Long-term effects of small doses of 1,25-dihydroxycholecalciferol in renal osteodystrophy. Ahmed KY; Varghese Z; Wills MR; Meinhard EA; Moorhead JF Lancet; 1978 Mar; 1(8065):629-32. PubMed ID: 76168 [TBL] [Abstract][Full Text] [Related]
87. [Effects of 1-alpha-hydroxyvitamin D 3 treatment of osteodystrophy in uremic patients treated with periodic hemodialysis]. Palmieri P; Albertazzi A; Cappelli P; Di Paolo B G Clin Med; 1981 Jul; 62(7):443-60. PubMed ID: 7308629 [No Abstract] [Full Text] [Related]
88. Bone disease in patients dialyzed with untreated water. Rashid A; Posen GA; Gray D; Jaworski ZF Med Instrum; 1974; 8(3):204-6. PubMed ID: 4838450 [No Abstract] [Full Text] [Related]
89. Serum hydroxyproline and renal osteodystrophy in patients maintained on haemodialysis. Goulding A; McChesney R; Irvine RO; Dixon SR N Z Med J; 1974 Dec; 80(530):540-4. PubMed ID: 4615274 [No Abstract] [Full Text] [Related]
90. Roentgen appearance of bone and soft tissue changes in chronic renal disease. Greenfield GB Am J Roentgenol Radium Ther Nucl Med; 1972 Dec; 116(4):749-57. PubMed ID: 4566090 [No Abstract] [Full Text] [Related]
92. Mineralized bone loss at different sites in dialysis patients: implications for prevention. Schober HC; Han ZH; Foldes AJ; Shih MS; Rao DS; Balena R; Parfitt AM J Am Soc Nephrol; 1998 Jul; 9(7):1225-33. PubMed ID: 9644632 [TBL] [Abstract][Full Text] [Related]
93. The effect of 1alpha-hydroxyvitamin D3 in pre-dialysis renal bone disease. Pierides AM; Ellis HA; Simpson W; Cook D; Kerr DN Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():109s-116s. PubMed ID: 606409 [TBL] [Abstract][Full Text] [Related]
94. [Radiography of the hands, with a mammographic technic, in the study and supervision of renal osteodystrophy. Patients undergoing periodic hemodialysis]. Bedani PL; Tamarozzi R; Farinelli R; Perini L; De Paoli Vitali E; Gilli P; Squerzanti R; Farinelli A Minerva Nefrol; 1983; 30(1):43-50. PubMed ID: 6843885 [No Abstract] [Full Text] [Related]
96. [Diet in the prevention of uremic osteodystrophy]. Maschio G; D'Angelo A; Bonucci E; Tessitore N; Lo Schiavo C; Lupo A; Valvo E; Chiaramonte S; Previato G; Fabris A; Saporiti E; Fiaschi E G Clin Med; 1980 May; 61(5):358-64. PubMed ID: 7450355 [No Abstract] [Full Text] [Related]
97. Vitamin D therapy in uremic osteodystrophy: theoretical and practical considerations. Popovtzer MM Int J Artif Organs; 1980 Jan; 3(1):1-4. PubMed ID: 7353907 [No Abstract] [Full Text] [Related]
98. Plasma parathormone, calcium and phosphorus in patients with renal osteodystrophy undergoing chronic hemodialysis. Genuth SM; Sherwood LM; Vertes V; Leonards JR J Clin Endocrinol Metab; 1970 Jan; 30(1):138-40. PubMed ID: 5409532 [No Abstract] [Full Text] [Related]
99. [Radiologic study of renal osteodystrophy]. Bilbao JI; Villaró J; San Julián M; Purroy A Rev Med Univ Navarra; 1982 Dec; 26(4):229-37. PubMed ID: 7182894 [No Abstract] [Full Text] [Related]